CHARLESTON, SC (WCSC) - New cancer-fighting technology recently installed at MUSC may give new hope to patients diagnosed with inoperable or surgically-complex tumors.
The first patient to use the technology, called TrueBeam STx, is scheduled for treatment on Wednesday at the MUSC Hollings Cancer Center.
"TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities," Dr. Joseph Jenrette III, chairman of the MUSC Department of Radiation Oncology, said in a written statement.
Its creators say TrueBeam can treat cancerous and non-cancerous tumors in the body, including the lung, brain, prostate, spine, liver, pancreas, kidney, bone and eye. It can also treat certain blood vessel abnormalities, and trigenimal neuralgia, a disorder that causes facial pain. The treatment involves a noninvasive, high-dose radiation precisely matched to the size and shape of the tumor, Jenrette said.
The technology is available at the main campus of MUSC in downtown Charleston and is expected to be available in Mount Pleasant in early 2015, according to the release.